Study of ORM-1153 in Acute Myeloid Leukemia (AML) With CD123 Expression
Study of ORM-1153 in Acute Myeloid Leukemia (AML) With CD123 Expression
Not yet recruiting · NCT07809906 · Registry updated 2026-09-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of ORM-1153 in Acute Myeloid Leukemia (AML) With CD123 Expression | Hemic and Lymphatic Diseases, Neoplasms by Site, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm | Not yet recruiting | Phase 1 | 2026-09-09 | NCT07809906 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Orum Therapeutics USA, Inc. | 1 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| MD Anderson Cancer Center | Houston | United States | 589 |
| START - Midwest | Grand Rapids | United States | 5 |